Cargando…
Modern imaging in Cushing’s disease
Management of Cushing’s disease is informed by dedicated imaging of the sella and parasellar regions. Although magnetic resonance imaging (MRI) remains the investigation of choice, a significant proportion (30–50%) of corticotroph tumours are so small as to render MRI indeterminate or negative when...
Autores principales: | Bashari, W. A., Gillett, D., MacFarlane, J., Powlson, A. S., Kolias, A. G., Mannion, R., Scoffings, D. J., Mendichovszky, I. A., Jones, J., Cheow, H. K., Koulouri, O., Gurnell, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587975/ https://www.ncbi.nlm.nih.gov/pubmed/35666391 http://dx.doi.org/10.1007/s11102-022-01236-w |
Ejemplares similares
-
Novel imaging techniques in refractory pituitary adenomas
por: MacFarlane, J, et al.
Publicado: (2023) -
Methods of 3D printing models of pituitary tumors
por: Gillett, Daniel, et al.
Publicado: (2021) -
Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction
por: Gillett, Daniel, et al.
Publicado: (2022) -
(11)C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy
por: Bashari, W. A., et al.
Publicado: (2022) -
Development of a bespoke phantom to optimize molecular PET imaging of pituitary tumors
por: Gillett, Daniel, et al.
Publicado: (2023)